VentriPoint Diagnostics (TSE:VPT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Ventripoint Diagnostics has successfully closed debt settlement agreements by issuing 128,900 common shares to settle $19,335 of debt owed to a former director and their holding company. This strategic move allows Ventripoint to conserve cash for future business development. The shares issued as part of this transaction are subject to approval by the TSX Venture Exchange.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
